Bildkälla: Stockfoto

Siili Solutions Q4: Headline figures broadly in line - SEB

Siili's H2 sales and EBITA came in broadly in line with our estimates, but the deviations were marginally negative. The organic growth in H2 was healthy at 11%. Looking at the guidance, we note that our pre-report estimates are close to the upper end of the guidance range.

Siili's H2 sales and EBITA came in broadly in line with our estimates, but the deviations were marginally negative. The organic growth in H2 was healthy at 11%. Looking at the guidance, we note that our pre-report estimates are close to the upper end of the guidance range.
Börsvärldens nyhetsbrev
ANNONSER